(Q28369506)

2

0 references

T Sugimoto

3

0 references

Y Tomura

4

0 references

K Wada

5

0 references

T Kusayama

6

0 references

J Tsukada

7

0 references

N Ishii

8

0 references

T Yatsu

9

0 references

W Uchida

10

0 references

A Tanaka

British Journal of Pharmacology

11

0 references

language of work or name

English

0 references

publication date

December 1998

0 references

published in

0 references

volume

125

0 references

issue

7

0 references

page(s)

1463-70

0 references

cites work

Characterization of the human liver vasopressin receptor. Profound differences between human and rat vasopressin-receptor-mediated responses suggest only a minor role for vasopressin in regulating human hepatic function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

Molecular cloning of the receptor for human antidiuretic hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Molecular and functional characterization of V1b vasopressin receptor in rat adrenal medulla

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

pEF-BOS, a powerful mammalian expression vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Effect of long-term treatment with selective vasopressin V1 and V2 receptor antagonist on the development of heart failure in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced hyperplasia and hypertrophy of cultured vascular smooth-muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

A rapid filtration assay for cAMP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Labelling of vasopressin and oxytocin receptors from the human uterus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Signal transduction of V1-vascular vasopressin receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Characterization of human platelet vasopressin receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Effects of vasopressin on human memory functions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021

Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702220

7 January 2021